Forsblom Erik, Frilander Hanna, Ruotsalainen Eeva, Järvinen Asko
Division of Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Open Forum Infect Dis. 2019 Nov 19;6(12):ofz495. doi: 10.1093/ofid/ofz495. eCollection 2019 Dec.
Formal infectious diseases specialist (IDS) consultation has been shown to improve short-term outcomes in bacteremia (SAB), but its effect on long-term outcomes lacks evaluation.
This retrospective study followed 367 methicillin-sensitive (MS) SAB patients for 10 years. The impact of formal IDS consultation on risk for new bacteremia and outcome during long-term follow-up was evaluated. Patients who died within 90 days were excluded to avoid interference from early deceased patients.
Three hundred four (83%) patients had formal IDS consultation, whereas 63 (17%) received informal or no IDS consultation. Formal consultation, compared with informal or lack of consultation, was associated with a reduced risk of new bacteremia caused by any pathogen within 1 year (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.18-0.84; = .014; 8% vs 17%) and within 3 years (OR, 0.39; 95% CI, 0.19-0.80; = .010; 9% vs 21%), whereas a trend toward lower risk was observed within 10 years (OR, 0.56; 95% CI, 0.29-1.08; = .079; 16% vs 25%). Formal consultation, compared with informal or lack of consultation, improved outcomes at 1 year (OR, 0.16; 95% CI, 0.06-0.44; < .001; 3% vs 14%), at 3 years (OR, 0.19; 95% CI, 0.09-0.42; < .001; 5% vs 22%), and at 10 years (OR, 0.43; 95% CI, 0.24-0.74; = .002; 27% vs 46%). Considering all prognostic parameters, formal consultation improved outcomes (HR, 0.42; 95% CI, 0.27-0.65; < .001) and lowered risk for any new bacteremia (OR, 0.45; 95% CI, 0.23-0.88; = .02) during 10 years of follow-up.
MS-SAB management by formal IDS consultation, compared with informal or lack of IDS consultation, reduces risk for new bacteremia episodes and improves long-term prognosis up to 10 years.
正式的感染性疾病专科医生(IDS)会诊已被证明可改善菌血症(SAB)的短期预后,但其对长期预后的影响尚缺乏评估。
这项回顾性研究对367例甲氧西林敏感(MS)的SAB患者进行了为期10年的随访。评估了正式的IDS会诊对长期随访期间新发菌血症风险和预后的影响。排除90天内死亡的患者以避免早期死亡患者的干扰。
304例(83%)患者接受了正式的IDS会诊,而63例(17%)接受了非正式或未接受IDS会诊。与非正式或未会诊相比,正式会诊与1年内(优势比[OR],0.39;95%置信区间[CI],0.18 - 0.84;P = 0.014;8%对17%)和3年内(OR,0.39;95% CI,0.19 - 0.80;P = 0.010;9%对21%)由任何病原体引起的新发菌血症风险降低相关,而在10年内观察到风险有降低趋势(OR,0.56;95% CI,0.29 - 1.08;P = 0.079;16%对25%)。与非正式或未会诊相比,正式会诊在1年时(OR,0.16;95% CI,0.06 - 0.44;P < 0.001;3%对14%)、3年时(OR,0.19;95% CI,0.09 - 0.42;P < 0.001;5%对22%)和10年时(OR,0.43;95% CI,0.24 - 0.74;P = 0.002;27%对46%)改善了预后。考虑所有预后参数,正式会诊在10年随访期间改善了预后(风险比[HR],0.42;95% CI,0.27 - 0.65;P < 0.001)并降低了任何新发菌血症的风险(OR,0.45;95% CI,0.23 - 0.88;P = 0.02)。
与非正式或未进行IDS会诊相比,通过正式的IDS会诊管理MS - SAB可降低新发菌血症发作的风险,并改善长达10年的长期预后。